CN113995133A - 包含委陵菜提取物或蓼蓝提取物的用于改善、预防或治疗肌肉萎缩的组合物 - Google Patents

包含委陵菜提取物或蓼蓝提取物的用于改善、预防或治疗肌肉萎缩的组合物 Download PDF

Info

Publication number: CN113995133A
Authority: CN; China
Prior art keywords: extract; muscle; polygonum tinctorium; composition; muscle atrophy
Prior art date: 2020-07-28
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Pending

Application number

CN202110711194.6A

Other languages

English (en)

Chinese (zh)

Inventor

石英美

苏宰贤

金孝静

姜允桓

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Korea Pharmaceutical Revitalization Institute

Original Assignee

Korea Pharmaceutical Revitalization Institute

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2020-07-28

Filing date

2021-06-25

Publication date

2022-02-01

2021-06-25 Application filed by Korea Pharmaceutical Revitalization Institute filed Critical Korea Pharmaceutical Revitalization Institute

2022-02-01 Publication of CN113995133A publication Critical patent/CN113995133A/zh

Status Pending legal-status Critical Current

Links

239000000284 extract Substances 0.000 title claims abstract description 132
201000000585 muscular atrophy Diseases 0.000 title claims abstract description 93
241000382362 Persicaria tinctoria Species 0.000 title claims abstract description 62
239000000203 mixture Substances 0.000 title claims abstract description 31
240000000103 Potentilla erecta Species 0.000 title claims abstract description 9
235000016551 Potentilla erecta Nutrition 0.000 title claims abstract description 9
206010028289 Muscle atrophy Diseases 0.000 claims abstract description 74
230000020763 muscle atrophy Effects 0.000 claims abstract description 72
241001531051 Potentilla chinensis Species 0.000 claims abstract description 32
239000004480 active ingredient Substances 0.000 claims abstract description 32
239000008194 pharmaceutical composition Substances 0.000 claims description 17
241001465754 Metazoa Species 0.000 claims description 10
235000013305 food Nutrition 0.000 claims description 7
230000000694 effects Effects 0.000 abstract description 35
102000003964 Histone deacetylase Human genes 0.000 abstract description 30
108090000353 Histone deacetylase Proteins 0.000 abstract description 30
210000003205 muscle Anatomy 0.000 abstract description 27
102100040669 F-box only protein 32 Human genes 0.000 abstract description 26
101710191029 F-box only protein 32 Proteins 0.000 abstract description 26
102100025014 E3 ubiquitin-protein ligase TRIM63 Human genes 0.000 abstract description 23
101710164910 E3 ubiquitin-protein ligase TRIM63 Proteins 0.000 abstract description 23
102000004472 Myostatin Human genes 0.000 abstract description 17
108010056852 Myostatin Proteins 0.000 abstract description 17
102000016970 Follistatin Human genes 0.000 abstract description 13
108010014612 Follistatin Proteins 0.000 abstract description 13
MEJYXFHCRXAUIL-UHFFFAOYSA-N 2-[carbamimidoyl(methyl)amino]acetic acid;hydrate Chemical compound O.NC(=N)N(C)CC(O)=O MEJYXFHCRXAUIL-UHFFFAOYSA-N 0.000 abstract description 9
229960004826 creatine monohydrate Drugs 0.000 abstract description 9
WAEXFXRVDQXREF-UHFFFAOYSA-N vorinostat Chemical compound ONC(=O)CCCCCCC(=O)NC1=CC=CC=C1 WAEXFXRVDQXREF-UHFFFAOYSA-N 0.000 abstract description 9
229960000237 vorinostat Drugs 0.000 abstract description 9
WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 abstract description 8
102000006275 Ubiquitin-Protein Ligases Human genes 0.000 abstract description 8
108010083111 Ubiquitin-Protein Ligases Proteins 0.000 abstract description 8
229940096998 ursolic acid Drugs 0.000 abstract description 8
PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 abstract description 8
230000001965 increasing effect Effects 0.000 abstract description 7
230000002401 inhibitory effect Effects 0.000 abstract description 7
102000004315 Forkhead Transcription Factors Human genes 0.000 abstract description 5
108090000852 Forkhead Transcription Factors Proteins 0.000 abstract description 5
230000012010 growth Effects 0.000 abstract description 5
239000003112 inhibitor Substances 0.000 abstract description 5
230000001105 regulatory effect Effects 0.000 abstract description 4
230000002018 overexpression Effects 0.000 abstract description 3
238000005728 strengthening Methods 0.000 abstract description 2
230000014509 gene expression Effects 0.000 description 33
210000000663 muscle cell Anatomy 0.000 description 25
241001092489 Potentilla Species 0.000 description 19
UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 17
229960003957 dexamethasone Drugs 0.000 description 17
102100035421 Forkhead box protein O3 Human genes 0.000 description 15
101000877681 Homo sapiens Forkhead box protein O3 Proteins 0.000 description 15
108090000623 proteins and genes Proteins 0.000 description 15
108010009306 Forkhead Box Protein O1 Proteins 0.000 description 14
102000009561 Forkhead Box Protein O1 Human genes 0.000 description 14
102000003676 Glucocorticoid Receptors Human genes 0.000 description 14
108090000079 Glucocorticoid Receptors Proteins 0.000 description 14
108020004999 messenger RNA Proteins 0.000 description 14
102000004169 proteins and genes Human genes 0.000 description 14
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
238000000034 method Methods 0.000 description 10
210000004027 cell Anatomy 0.000 description 8
238000002474 experimental method Methods 0.000 description 7
238000000605 extraction Methods 0.000 description 7
102000009572 RNA Polymerase II Human genes 0.000 description 6
108010009460 RNA Polymerase II Proteins 0.000 description 6
230000037257 muscle growth Effects 0.000 description 6
210000002027 skeletal muscle Anatomy 0.000 description 6
239000000126 substance Substances 0.000 description 6
238000002487 chromatin immunoprecipitation Methods 0.000 description 5
230000007423 decrease Effects 0.000 description 5
230000001419 dependent effect Effects 0.000 description 5
239000003814 drug Substances 0.000 description 5
239000003862 glucocorticoid Substances 0.000 description 5
239000000243 solution Substances 0.000 description 5
239000006144 Dulbecco’s modiﬁed Eagle's medium Substances 0.000 description 4
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
230000032683 aging Effects 0.000 description 4
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 4
238000006243 chemical reaction Methods 0.000 description 4
230000003247 decreasing effect Effects 0.000 description 4
230000004069 differentiation Effects 0.000 description 4
229940079593 drug Drugs 0.000 description 4
238000011156 evaluation Methods 0.000 description 4
229940121372 histone deacetylase inhibitor Drugs 0.000 description 4
239000003276 histone deacetylase inhibitor Substances 0.000 description 4
239000004615 ingredient Substances 0.000 description 4
210000003098 myoblast Anatomy 0.000 description 4
230000009467 reduction Effects 0.000 description 4
238000000638 solvent extraction Methods 0.000 description 4
239000003270 steroid hormone Substances 0.000 description 4
150000003431 steroids Chemical class 0.000 description 4
239000006228 supernatant Substances 0.000 description 4
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
241000196324 Embryophyta Species 0.000 description 3
XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
102000040945 Transcription factor Human genes 0.000 description 3
108091023040 Transcription factor Proteins 0.000 description 3
230000037396 body weight Effects 0.000 description 3
238000005119 centrifugation Methods 0.000 description 3
230000002638 denervation Effects 0.000 description 3
206010012601 diabetes mellitus Diseases 0.000 description 3
239000002552 dosage form Substances 0.000 description 3
238000009547 dual-energy X-ray absorptiometry Methods 0.000 description 3
239000000839 emulsion Substances 0.000 description 3
230000002255 enzymatic effect Effects 0.000 description 3
230000006870 function Effects 0.000 description 3
239000008103 glucose Substances 0.000 description 3
230000007246 mechanism Effects 0.000 description 3
230000004060 metabolic process Effects 0.000 description 3
201000006938 muscular dystrophy Diseases 0.000 description 3
238000010606 normalization Methods 0.000 description 3
239000000843 powder Substances 0.000 description 3
230000001737 promoting effect Effects 0.000 description 3
208000001076 sarcopenia Diseases 0.000 description 3
239000002904 solvent Substances 0.000 description 3
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
102000007469 Actins Human genes 0.000 description 2
108010085238 Actins Proteins 0.000 description 2
101001059929 Caenorhabditis elegans Forkhead box protein O Proteins 0.000 description 2
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
108020004414 DNA Proteins 0.000 description 2
108010067770 Endopeptidase K Proteins 0.000 description 2
WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
102000002812 Heat-Shock Proteins Human genes 0.000 description 2
108010004889 Heat-Shock Proteins Proteins 0.000 description 2
102100022537 Histone deacetylase 6 Human genes 0.000 description 2
108010033040 Histones Proteins 0.000 description 2
102000006947 Histones Human genes 0.000 description 2
101000899330 Homo sapiens Histone deacetylase 6 Proteins 0.000 description 2
108010001336 Horseradish Peroxidase Proteins 0.000 description 2
235000000177 Indigofera tinctoria Nutrition 0.000 description 2
206010061218 Inflammation Diseases 0.000 description 2
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
239000004472 Lysine Substances 0.000 description 2
241000699666 Mus <mouse, genus> Species 0.000 description 2
102000008934 Muscle Proteins Human genes 0.000 description 2
108010074084 Muscle Proteins Proteins 0.000 description 2
239000000020 Nitrocellulose Substances 0.000 description 2
108010047956 Nucleosomes Proteins 0.000 description 2
208000008589 Obesity Diseases 0.000 description 2
238000011529 RT qPCR Methods 0.000 description 2
101710120037 Toxin CcdB Proteins 0.000 description 2
102100029709 Tripartite motif-containing protein 54 Human genes 0.000 description 2
101710154817 Tripartite motif-containing protein 54 Proteins 0.000 description 2
241000209140 Triticum Species 0.000 description 2
235000021307 Triticum Nutrition 0.000 description 2
102000004243 Tubulin Human genes 0.000 description 2
108090000704 Tubulin Proteins 0.000 description 2
125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 2
210000004404 adrenal cortex Anatomy 0.000 description 2
239000000443 aerosol Substances 0.000 description 2
238000004458 analytical method Methods 0.000 description 2
229940121375 antifungal agent Drugs 0.000 description 2
230000004900 autophagic degradation Effects 0.000 description 2
RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
239000002775 capsule Substances 0.000 description 2
238000004113 cell culture Methods 0.000 description 2
230000004663 cell proliferation Effects 0.000 description 2
235000013339 cereals Nutrition 0.000 description 2
239000002299 complementary DNA Substances 0.000 description 2
CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 description 2
230000001186 cumulative effect Effects 0.000 description 2
230000001086 cytosolic effect Effects 0.000 description 2
230000034994 death Effects 0.000 description 2
239000003085 diluting agent Substances 0.000 description 2
201000010099 disease Diseases 0.000 description 2
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
239000000975 dye Substances 0.000 description 2
208000001848 dysentery Diseases 0.000 description 2
239000012149 elution buffer Substances 0.000 description 2
230000002708 enhancing effect Effects 0.000 description 2
239000000469 ethanolic extract Substances 0.000 description 2
229920000159 gelatin Polymers 0.000 description 2
235000019322 gelatine Nutrition 0.000 description 2
238000003119 immunoblot Methods 0.000 description 2
230000006872 improvement Effects 0.000 description 2
229940097275 indigo Drugs 0.000 description 2
COHYTHOBJLSHDF-UHFFFAOYSA-N indigo powder Natural products N1C2=CC=CC=C2C(=O)C1=C1C(=O)C2=CC=CC=C2N1 COHYTHOBJLSHDF-UHFFFAOYSA-N 0.000 description 2
230000004054 inflammatory process Effects 0.000 description 2
230000005764 inhibitory process Effects 0.000 description 2
235000015122 lemonade Nutrition 0.000 description 2
239000000865 liniment Substances 0.000 description 2
239000007937 lozenge Substances 0.000 description 2
239000012139 lysis buffer Substances 0.000 description 2
HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
239000002609 medium Substances 0.000 description 2
239000012528 membrane Substances 0.000 description 2
LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
210000003365 myofibril Anatomy 0.000 description 2
VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
230000031990 negative regulation of inflammatory response Effects 0.000 description 2
229920001220 nitrocellulos Polymers 0.000 description 2
210000001623 nucleosome Anatomy 0.000 description 2
235000020824 obesity Nutrition 0.000 description 2
239000003960 organic solvent Substances 0.000 description 2
239000000546 pharmaceutical excipient Substances 0.000 description 2
230000008569 process Effects 0.000 description 2
QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
230000012121 regulation of immune response Effects 0.000 description 2
210000002966 serum Anatomy 0.000 description 2
239000000725 suspension Substances 0.000 description 2
235000020357 syrup Nutrition 0.000 description 2
230000034512 ubiquitination Effects 0.000 description 2
238000010798 ubiquitination Methods 0.000 description 2
239000011782 vitamin Substances 0.000 description 2
235000013343 vitamin Nutrition 0.000 description 2
229940088594 vitamin Drugs 0.000 description 2
229930003231 vitamin Natural products 0.000 description 2
PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
229920000936 Agarose Polymers 0.000 description 1
GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
241000705930 Broussonetia papyrifera Species 0.000 description 1
DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 1
125000006519 CCH3 Chemical group 0.000 description 1
241000219504 Caryophyllales Species 0.000 description 1
PTHCMJGKKRQCBF-UHFFFAOYSA-N Cellulose, microcrystalline Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC)C(CO)O1 PTHCMJGKKRQCBF-UHFFFAOYSA-N 0.000 description 1
FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
239000004386 Erythritol Substances 0.000 description 1
UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
206010017553 Furuncle Diseases 0.000 description 1
108010010803 Gelatin Proteins 0.000 description 1
239000001828 Gelatine Substances 0.000 description 1
102100031181 Glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 1
208000034507 Haematemesis Diseases 0.000 description 1
208000000616 Hemoptysis Diseases 0.000 description 1
LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
206010023126 Jaundice Diseases 0.000 description 1
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
235000010643 Leucaena leucocephala Nutrition 0.000 description 1
240000007472 Leucaena leucocephala Species 0.000 description 1
241000124008 Mammalia Species 0.000 description 1
229930195725 Mannitol Natural products 0.000 description 1
229920000168 Microcrystalline cellulose Polymers 0.000 description 1
241000699670 Mus sp. Species 0.000 description 1
208000021642 Muscular disease Diseases 0.000 description 1
201000009623 Myopathy Diseases 0.000 description 1
DTERQYGMUDWYAZ-ZETCQYMHSA-N N(6)-acetyl-L-lysine Chemical compound CC(=O)NCCCC[C@H]([NH3+])C([O-])=O DTERQYGMUDWYAZ-ZETCQYMHSA-N 0.000 description 1
HRNLUBSXIHFDHP-UHFFFAOYSA-N N-(2-aminophenyl)-4-[[[4-(3-pyridinyl)-2-pyrimidinyl]amino]methyl]benzamide Chemical compound NC1=CC=CC=C1NC(=O)C(C=C1)=CC=C1CNC1=NC=CC(C=2C=NC=CC=2)=N1 HRNLUBSXIHFDHP-UHFFFAOYSA-N 0.000 description 1
WWGBHDIHIVGYLZ-UHFFFAOYSA-N N-[4-[3-[[[7-(hydroxyamino)-7-oxoheptyl]amino]-oxomethyl]-5-isoxazolyl]phenyl]carbamic acid tert-butyl ester Chemical compound C1=CC(NC(=O)OC(C)(C)C)=CC=C1C1=CC(C(=O)NCCCCCCC(=O)NO)=NO1 WWGBHDIHIVGYLZ-UHFFFAOYSA-N 0.000 description 1
108091005804 Peptidases Proteins 0.000 description 1
102000035195 Peptidases Human genes 0.000 description 1
241000219050 Polygonaceae Species 0.000 description 1
241000205407 Polygonum Species 0.000 description 1
235000004789 Rosa xanthina Nutrition 0.000 description 1
241000220222 Rosaceae Species 0.000 description 1
229920002684 Sepharose Polymers 0.000 description 1
235000019764 Soybean Meal Nutrition 0.000 description 1
229920002472 Starch Polymers 0.000 description 1
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
229930006000 Sucrose Natural products 0.000 description 1
208000027418 Wounds and injury Diseases 0.000 description 1
TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
240000008042 Zea mays Species 0.000 description 1
235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
235000002017 Zea mays subsp mays Nutrition 0.000 description 1
230000021736 acetylation Effects 0.000 description 1
238000006640 acetylation reaction Methods 0.000 description 1
239000002253 acid Substances 0.000 description 1
230000009471 action Effects 0.000 description 1
235000013334 alcoholic beverage Nutrition 0.000 description 1
150000001298 alcohols Chemical class 0.000 description 1
229940072056 alginate Drugs 0.000 description 1
235000010443 alginic acid Nutrition 0.000 description 1
229920000615 alginic acid Polymers 0.000 description 1
150000001413 amino acids Chemical class 0.000 description 1
239000005557 antagonist Substances 0.000 description 1
230000002605 anti-dotal effect Effects 0.000 description 1
239000003146 anticoagulant agent Substances 0.000 description 1
229940127219 anticoagulant drug Drugs 0.000 description 1
235000013361 beverage Nutrition 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
210000004369 blood Anatomy 0.000 description 1
239000008280 blood Substances 0.000 description 1
239000001045 blue dye Substances 0.000 description 1
235000008429 bread Nutrition 0.000 description 1
238000010805 cDNA synthesis kit Methods 0.000 description 1
229960001948 caffeine Drugs 0.000 description 1
VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
239000001506 calcium phosphate Substances 0.000 description 1
229910000389 calcium phosphate Inorganic materials 0.000 description 1
235000011010 calcium phosphates Nutrition 0.000 description 1
239000000378 calcium silicate Substances 0.000 description 1
229910052918 calcium silicate Inorganic materials 0.000 description 1
235000012241 calcium silicate Nutrition 0.000 description 1
OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
125000004432 carbon atom Chemical group C* 0.000 description 1
239000000969 carrier Substances 0.000 description 1
230000024245 cell differentiation Effects 0.000 description 1
230000004656 cell transport Effects 0.000 description 1
239000001913 cellulose Substances 0.000 description 1
229920002678 cellulose Polymers 0.000 description 1
235000010980 cellulose Nutrition 0.000 description 1
239000003153 chemical reaction reagent Substances 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
235000015218 chewing gum Nutrition 0.000 description 1
235000019219 chocolate Nutrition 0.000 description 1
235000014510 cooky Nutrition 0.000 description 1
235000005822 corn Nutrition 0.000 description 1
239000006071 cream Substances 0.000 description 1
229960003624 creatine Drugs 0.000 description 1
239000006046 creatine Substances 0.000 description 1
238000012258 culturing Methods 0.000 description 1
230000006378 damage Effects 0.000 description 1
230000006196 deacetylation Effects 0.000 description 1
238000003381 deacetylation reaction Methods 0.000 description 1
238000001514 detection method Methods 0.000 description 1
239000008121 dextrose Substances 0.000 description 1
238000010586 diagram Methods 0.000 description 1
230000003828 downregulation Effects 0.000 description 1
239000003937 drug carrier Substances 0.000 description 1
230000004064 dysfunction Effects 0.000 description 1
239000003995 emulsifying agent Substances 0.000 description 1
UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
235000019414 erythritol Nutrition 0.000 description 1
229940009714 erythritol Drugs 0.000 description 1
239000003889 eye drop Substances 0.000 description 1
229940012356 eye drops Drugs 0.000 description 1
239000003885 eye ointment Substances 0.000 description 1
210000001512 fast-twitch muscle fiber Anatomy 0.000 description 1
239000000945 filler Substances 0.000 description 1
QOLIPNRNLBQTAU-UHFFFAOYSA-N flavan Chemical class C1CC2=CC=CC=C2OC1C1=CC=CC=C1 QOLIPNRNLBQTAU-UHFFFAOYSA-N 0.000 description 1
235000013312 flour Nutrition 0.000 description 1
239000007850 fluorescent dye Substances 0.000 description 1
101150046266 foxo gene Proteins 0.000 description 1
239000000499 gel Substances 0.000 description 1
239000008273 gelatin Substances 0.000 description 1
239000007903 gelatin capsule Substances 0.000 description 1
235000011852 gelatine desserts Nutrition 0.000 description 1
230000002068 genetic effect Effects 0.000 description 1
108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 1
235000011187 glycerol Nutrition 0.000 description 1
239000008187 granular material Substances 0.000 description 1
235000013402 health food Nutrition 0.000 description 1
208000031169 hemorrhagic disease Diseases 0.000 description 1
FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
235000015243 ice cream Nutrition 0.000 description 1
238000007654 immersion Methods 0.000 description 1
230000036039 immunity Effects 0.000 description 1
239000003978 infusion fluid Substances 0.000 description 1
239000007924 injection Substances 0.000 description 1
208000014674 injury Diseases 0.000 description 1
229910052500 inorganic mineral Inorganic materials 0.000 description 1
235000015110 jellies Nutrition 0.000 description 1
239000008101 lactose Substances 0.000 description 1
230000033001 locomotion Effects 0.000 description 1
230000007774 longterm Effects 0.000 description 1
239000000314 lubricant Substances 0.000 description 1
235000019359 magnesium stearate Nutrition 0.000 description 1
229940057948 magnesium stearate Drugs 0.000 description 1
239000000845 maltitol Substances 0.000 description 1
VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
235000010449 maltitol Nutrition 0.000 description 1
229940035436 maltitol Drugs 0.000 description 1
239000000594 mannitol Substances 0.000 description 1
235000010355 mannitol Nutrition 0.000 description 1
239000000463 material Substances 0.000 description 1
235000013372 meat Nutrition 0.000 description 1
HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
229920000609 methyl cellulose Polymers 0.000 description 1
239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
239000001923 methylcellulose Substances 0.000 description 1
235000010981 methylcellulose Nutrition 0.000 description 1
ZGEGCLOFRBLKSE-UHFFFAOYSA-N methylene hexane Natural products CCCCCC=C ZGEGCLOFRBLKSE-UHFFFAOYSA-N 0.000 description 1
229960002216 methylparaben Drugs 0.000 description 1
235000019813 microcrystalline cellulose Nutrition 0.000 description 1
239000008108 microcrystalline cellulose Substances 0.000 description 1
229940016286 microcrystalline cellulose Drugs 0.000 description 1
239000011707 mineral Substances 0.000 description 1
239000002480 mineral oil Substances 0.000 description 1
235000010446 mineral oil Nutrition 0.000 description 1
229940042472 mineral oil Drugs 0.000 description 1
230000004065 mitochondrial dysfunction Effects 0.000 description 1
230000004048 modification Effects 0.000 description 1
238000012986 modification Methods 0.000 description 1
210000000107 myocyte Anatomy 0.000 description 1
UPSFMJHZUCSEHU-JYGUBCOQSA-N n-[(2s,3r,4r,5s,6r)-2-[(2r,3s,4r,5r,6s)-5-acetamido-4-hydroxy-2-(hydroxymethyl)-6-(4-methyl-2-oxochromen-7-yl)oxyoxan-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide Chemical compound CC(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1[C@H](O)[C@@H](NC(C)=O)[C@H](OC=2C=C3OC(=O)C=C(C)C3=CC=2)O[C@@H]1CO UPSFMJHZUCSEHU-JYGUBCOQSA-N 0.000 description 1
201000009240 nasopharyngitis Diseases 0.000 description 1
235000012149 noodles Nutrition 0.000 description 1
230000008506 pathogenesis Effects 0.000 description 1
230000001575 pathological effect Effects 0.000 description 1
239000002304 perfume Substances 0.000 description 1
230000035790 physiological processes and functions Effects 0.000 description 1
239000000049 pigment Substances 0.000 description 1
239000006187 pill Substances 0.000 description 1
235000013550 pizza Nutrition 0.000 description 1
239000001267 polyvinylpyrrolidone Substances 0.000 description 1
235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
238000002360 preparation method Methods 0.000 description 1
239000003755 preservative agent Substances 0.000 description 1
230000002265 prevention Effects 0.000 description 1
230000000069 prophylactic effect Effects 0.000 description 1
239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
229960003415 propylparaben Drugs 0.000 description 1
238000001243 protein synthesis Methods 0.000 description 1
230000017854 proteolysis Effects 0.000 description 1
238000000746 purification Methods 0.000 description 1
235000011888 snacks Nutrition 0.000 description 1
238000002791 soaking Methods 0.000 description 1
238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
238000000527 sonication Methods 0.000 description 1
239000000600 sorbitol Substances 0.000 description 1
235000010356 sorbitol Nutrition 0.000 description 1
239000004455 soybean meal Substances 0.000 description 1
239000008107 starch Substances 0.000 description 1
235000019698 starch Nutrition 0.000 description 1
239000000758 substrate Substances 0.000 description 1
239000005720 sucrose Substances 0.000 description 1
239000000829 suppository Substances 0.000 description 1
230000008961 swelling Effects 0.000 description 1
239000000454 talc Substances 0.000 description 1
229910052623 talc Inorganic materials 0.000 description 1
229940033134 talc Drugs 0.000 description 1
235000012222 talc Nutrition 0.000 description 1
229940124597 therapeutic agent Drugs 0.000 description 1
238000002560 therapeutic procedure Methods 0.000 description 1
231100000167 toxic agent Toxicity 0.000 description 1
239000003440 toxic substance Substances 0.000 description 1
230000014616 translation Effects 0.000 description 1
QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
RTKIYFITIVXBLE-QEQCGCAPSA-N trichostatin A Chemical compound ONC(=O)/C=C/C(/C)=C/[C@@H](C)C(=O)C1=CC=C(N(C)C)C=C1 RTKIYFITIVXBLE-QEQCGCAPSA-N 0.000 description 1
150000003722 vitamin derivatives Chemical class 0.000 description 1
239000003643 water by type Substances 0.000 description 1
239000000080 wetting agent Substances 0.000 description 1
235000014101 wine Nutrition 0.000 description 1
239000000811 xylitol Substances 0.000 description 1
235000010447 xylitol Nutrition 0.000 description 1
HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
229960002675 xylitol Drugs 0.000 description 1

Images

Classifications

- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/316—Foods, ingredients or supplements having a functional effect on health having an effect on regeneration or building of ligaments or muscles

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Natural Medicines & Medicinal Plants (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Mycology (AREA)
Botany (AREA)
Polymers & Plastics (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Biotechnology (AREA)
Food Science & Technology (AREA)
Alternative & Traditional Medicine (AREA)
Epidemiology (AREA)
Microbiology (AREA)
Medical Informatics (AREA)
Zoology (AREA)
Animal Husbandry (AREA)
General Chemical & Material Sciences (AREA)
Physical Education & Sports Medicine (AREA)
Neurology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Nutrition Science (AREA)
Orthopedic Medicine & Surgery (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Molecular Biology (AREA)
Physiology (AREA)
Medicines Containing Plant Substances (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

CN202110711194.6A 2020-07-28 2021-06-25 包含委陵菜提取物或蓼蓝提取物的用于改善、预防或治疗肌肉萎缩的组合物 Pending CN113995133A (zh)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
KR10-2020-0093966		2020-07-28
KR1020200093966A KR102459434B1 (ko)	2020-07-28	2020-07-28	위릉채 추출물 또는 쪽 추출물을 함유하는 근위축 개선, 예방 또는 치료용 조성물

Publications (1)

Publication Number	Publication Date
CN113995133A true CN113995133A (zh)	2022-02-01

Family

ID=79920951

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CN202110711194.6A Pending CN113995133A (zh)	2020-07-28	2021-06-25	包含委陵菜提取物或蓼蓝提取物的用于改善、预防或治疗肌肉萎缩的组合物

Country Status (2)

Country	Link
KR (1)	KR102459434B1 (ko)
CN (1)	CN113995133A (ko)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR20230138595A (ko)	2022-03-24	2023-10-05	주식회사 케이에스비튜젠	레보드로프로피진을 유효성분으로 포함하는 근육질환의 예방, 치료 또는 개선용 조성물
KR20230149171A (ko)	2022-04-19	2023-10-26	고려대학교 산학협력단	프로피오니박테리움 프레우덴레키 ｍｊ２ 균주를 유효성분으로 함유하는 근육질환의 예방 또는 치료용 조성물
KR20240074961A (ko)	2022-11-15	2024-05-29	한국한의약진흥원	저분자 성분의 함량 증진을 위한 경옥고의 가공방법, 이렇게 얻어진 미세 콜로이드 분산체 및 이를 포함하는 조성물
KR20240070948A (ko)	2022-11-15	2024-05-22	한국한의약진흥원	지용성 활성성분의 수용해도 증진을 위한 쌍화탕의 가공방법, 이렇게 얻어진 미세 콜로이드 분산체 및 이를 포함하는 조성물

Citations (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN103356767A (zh) *	2013-08-08	2013-10-23	成都乾坤动物药业有限公司	一种治疗细菌性腹泻的兽用药物组合物及其制备方法和用途
KR20140104652A (ko) *	2013-02-21	2014-08-29	충남대학교산학협력단	딱지꽃 추출물을 유효성분으로 포함하는 항인플루엔자용 조성물
CN107137591A (zh) *	2017-05-20	2017-09-08	朱黎明	一种治疗痿病的中药组合物
CN108348565A (zh) *	2015-05-26	2018-07-31	新树有限公司	一种含有桔梗提取物的用于预防和治疗肌肉疾病或改善肌肉功能的组合物
KR20190048794A (ko) *	2017-10-31	2019-05-09	동의대학교 산학협력단	상엽 추출물을 유효 성분으로 포함하는 근위축 예방 및 개선용 조성물

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR101671713B1 (ko)	2015-05-19	2016-11-02	숙명여자대학교 산학협력단	닥나무 유래 플라반 유도체를 유효성분으로 함유하는 근육위축증 예방 및 치료용 약학적 조성물

2020
- 2020-07-28 KR KR1020200093966A patent/KR102459434B1/ko active IP Right Grant
2021
- 2021-06-25 CN CN202110711194.6A patent/CN113995133A/zh active Pending

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR20140104652A (ko) *	2013-02-21	2014-08-29	충남대학교산학협력단	딱지꽃 추출물을 유효성분으로 포함하는 항인플루엔자용 조성물
CN103356767A (zh) *	2013-08-08	2013-10-23	成都乾坤动物药业有限公司	一种治疗细菌性腹泻的兽用药物组合物及其制备方法和用途
CN108348565A (zh) *	2015-05-26	2018-07-31	新树有限公司	一种含有桔梗提取物的用于预防和治疗肌肉疾病或改善肌肉功能的组合物
CN107137591A (zh) *	2017-05-20	2017-09-08	朱黎明	一种治疗痿病的中药组合物
KR20190048794A (ko) *	2017-10-31	2019-05-09	동의대학교 산학협력단	상엽 추출물을 유효 성분으로 포함하는 근위축 예방 및 개선용 조성물

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
CHUN CHEN 等: "Effect of Quercetin on Dexamethasone-Induced C2C12 Skeletal Muscle Cell Injury", MOLECULES, vol. 25, no. 14, pages 3267 *
FRANCESCA RATTI 等: "Histone Deacetylase 6 Is a FoxO Transcription Factordependent Effector in Skeletal Muscle Atrophy", THE JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 29, no. 7, pages 4215 *
NGOC HOAN LE 等: ""Quercetin Protects against Obesity-Induced Skeletal Muscle Inflammation and Atrophy", MEDIATORS OF INFLAMMATION, vol. 24, pages 1 *
SUBHANKAR BISWAS 等: "Evaluation of Novel 3-Hydroxyflavone Analogues as HDAC Inhibitors against Colorectal Cancer", ADVANCES IN PHARMACOLOGICAL SCIENCES, pages 6 *
赵川;唐生安;段宏泉;: "委陵菜抗糖尿病有效成分提取研究", 中药材, vol. 33, no. 2, pages 276 *

Also Published As

Publication number	Publication date
KR20220014187A (ko)	2022-02-04
KR102459434B1 (ko)	2022-10-25

Legal Events

Date	Code	Title
2022-02-01	PB01	Publication
2022-02-01	PB01	Publication
2022-02-22	SE01	Entry into force of request for substantive examination
2022-02-22	SE01	Entry into force of request for substantive examination

Publication	Publication Date	Title
CN113995133A (zh)	2022-02-01	包含委陵菜提取物或蓼蓝提取物的用于改善、预防或治疗肌肉萎缩的组合物
KR102459500B1 (ko)	2022-10-26	퀘르세틴 배당체를 함유하는 근위축 억제제
US20180085417A1 (en)	2018-03-29	Use of kaempferia parviflora wall. ex. baker extracts or flavone compound for preventing or treating muscle diseases, or improving muscle function
CN105796546B (zh)	2020-03-03	包含丁香脂素的sirt1活化剂
WO2006043671A1 (ja)	2006-04-27	転写因子Ｎｒｆ２活性化剤およびその機能が付与された食品
Xie et al.	2018	Inhibition of autophagy reverses alcohol-induced hepatic stellate cells activation through activation of Nrf2-Keap1-ARE signaling pathway
JP2012516842A (ja)	2012-07-26	代謝症候群の抑制のためのスファランサス・インディクスおよびガルシニア・マンゴスターナ由来の組成物
US20170232033A1 (en)	2017-08-17	Methods and materials related to nutritional supplement compositions containing a potato polysaccharide preparation
Zhang et al.	2022	FTZ protects against cardiac hypertrophy and oxidative injury via microRNA-214/SIRT3 signaling pathway
KR101673988B1 (ko)	2016-11-08	피부암의 치료 또는 전이 억제용 조성물
CN103415299B (zh)	2017-02-08	用于抗氧化和减轻由亚洲沙尘对皮肤造成的有害作用的组合物
KR20100065913A (ko)	2010-06-17	감태 추출물을 이용하여 신경퇴행성 질병을 치료하거나 그 증상을 완화 또는 방지하기 위한 조성물
EP2351559B1 (en)	2015-08-12	Novel use of panduratin derivative or boesenbergia pandurata extract
Liao et al.	2017	Cinnamon extracts exert intrapancreatic cytoprotection against streptozotocin in vivo
KR20220113912A (ko)	2022-08-17	피마자 추출물을 유효성분으로 포함하는 근육 질환 예방, 개선 또는 치료용 조성물
KR20050103185A (ko)	2005-10-27	출혈과 관련된 신경계 손상의 치료 방법
KR20220157849A (ko)	2022-11-29	이노토디올을 포함하는 근육 질환의 예방 또는 치료용 조성물
US10183048B2 (en)	2019-01-22	Composition for promoting the activity of peroxisome proliferator-activated receptor-delta
KR101669717B1 (ko)	2016-10-27	캡시코시드 g를 포함하는 항비만 조성물
KR102249535B1 (ko)	2021-05-07	알카닌을 유효성분으로 포함하는 대사성 질환용 조성물
KR102430640B1 (ko)	2022-08-16	지방 세포 분화 억제용 조성물 및 지방 세포 분화 억제 물질의 스크리닝 방법
KR20190075004A (ko)	2019-06-28	데커신 또는 데커시놀 안젤레이트를 유효성분으로 함유하는 복부내장지방 감소용 식품 조성물 또는 약학 조성물
KR100443264B1 (ko)	2004-08-04	구아바로부터 얻은 단백질 타이로신 탈인산화 효소 １ｂ 저해용 활성분획 추출물
KR101654977B1 (ko)	2016-09-07	키레놀 또는 시게스벡키아 오리엔탈리스 추출물을 포함하는 항비만용 조성물
KR102487438B1 (ko)	2023-01-11	구절초 추출물을 유효성분으로 포함하는 근육 질환 예방, 개선 또는 치료용 조성물